Blocking HTLV-1/2 silent transmission in Brazil: Current public health policies and proposal for additional strategies

PLoS Negl Trop Dis. 2021 Sep 23;15(9):e0009717. doi: 10.1371/journal.pntd.0009717. eCollection 2021 Sep.

Abstract

Human T-cell lymphotropic viruses 1 and 2 (HTLV-1/2) are relatively common in Brazil but remain silent and neglected infections. HTLV-1 is associated with a range of diseases with high morbidity and mortality. There is no curative treatment for this lifelong infection, so measures to prevent transmission are essential. This narrative review discusses HTLV-1/2 transmission routes and measures to prevent its continuous dissemination. The public health policies that are currently implemented in Brazil to avoid HTLV-1/2 transmission are addressed, and further strategies are proposed.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Brazil / epidemiology
  • HTLV-I Infections / epidemiology
  • HTLV-I Infections / transmission*
  • HTLV-I Infections / virology
  • HTLV-II Infections / epidemiology
  • HTLV-II Infections / transmission*
  • HTLV-II Infections / virology
  • Health Policy
  • Human T-lymphotropic virus 1 / genetics
  • Human T-lymphotropic virus 1 / physiology*
  • Human T-lymphotropic virus 2 / genetics
  • Human T-lymphotropic virus 2 / physiology*
  • Humans
  • Public Policy